TVTX
Travere Therapeutics, Inc.Company with tickers: TVTX
CIK
1438533
CUSIP
89422G107
Shares Outstanding
92,992,905
13F Activity (30d)
177 filings
153 filers
Quarterly earnings calls grouped as a single event — the transcript, the 8-K earnings release, and (where available) the audio and slide deck. Each badge shows which artefacts have landed for that quarter.
| Period | Call date | Event | Artefacts | Open |
|---|---|---|---|---|
| FY2026 Q1 | 2026-03-31 | Travere Therapeutics, Inc. Q1 FY2026 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2025 Q4 | 2025-12-31 | Travere Therapeutics, Inc. Q4 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2025 Q3 | 2025-09-30 | Travere Therapeutics, Inc. Q3 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2025 Q2 | 2025-06-30 | Travere Therapeutics, Inc. Q2 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2025 Q1 | 2025-03-31 | Travere Therapeutics, Inc. Q1 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2024 Q4 | 2024-12-31 | Travere Therapeutics, Inc. Q4 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2024 Q3 | 2024-09-30 | Travere Therapeutics, Inc. Q3 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2024 Q2 | 2024-06-30 | Travere Therapeutics, Inc. Q2 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2024 Q1 | 2024-03-31 | Travere Therapeutics, Inc. Q1 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2023 Q4 | 2023-12-31 | Travere Therapeutics, Inc. Q4 FY2023 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2023 Q2 | 2023-06-30 | Travere Therapeutics, Inc. Q2 FY2023 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2023 Q1 | 2023-03-31 | Travere Therapeutics, Inc. Q1 FY2023 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2022 Q4 | 2022-12-31 | Travere Therapeutics, Inc. Q4 FY2022 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2022 Q3 | 2022-09-30 | Travere Therapeutics, Inc. Q3 FY2022 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2022 Q2 | 2022-06-30 | Travere Therapeutics, Inc. Q2 FY2022 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2022 Q1 | 2022-03-31 | Travere Therapeutics, Inc. Q1 FY2022 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2021 Q4 | 2021-12-31 | Travere Therapeutics, Inc. Q4 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2021 Q3 | 2021-09-30 | Travere Therapeutics, Inc. Q3 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2021 Q2 | 2021-06-30 | Travere Therapeutics, Inc. Q2 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2021 Q1 | 2021-03-31 | Travere Therapeutics, Inc. Q1 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2020 Q4 | 2020-12-31 | Travere Therapeutics, Inc. Q4 FY2020 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2020 Q3 | 2020-09-30 | Travere Therapeutics, Inc. Q3 FY2020 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2020 Q2 | 2020-06-30 | Travere Therapeutics, Inc. Q2 FY2020 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2020 Q1 | 2020-03-31 | Travere Therapeutics, Inc. Q1 FY2020 Earnings Call |
Audio
Transcript
Slides
8-K
|
Showing 1–24 of 24 earnings calls